Senior insider sale
VANDA PHARMACEUTICALS INC. — senior position signals high conviction
$32.2K
7K shares
What this filing means
MITCHELL STEPHEN RAY plans to sell 7K shares of VANDA PHARMACEUTICALS INC. valued at approximately $32.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/13/2025ACC: 0000950170-25-086506
Director
Since Feb 2020
7K
Shares to sell
$32.2K
Approx. market value
7K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Vesting/Settlement of Restricted Stock Units
Compensation
6/16/2023
685.00Vesting/Settlement of Restricted Stock Units
Compensation
6/10/2022
2.30KVesting/Settlement of Restricted Stock Units
Compensation
6/11/2021
4.01KTotal acquired7K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/16/2023 | Vesting/Settlement of Restricted Stock Units Compensation | 685.00 | — |
6/10/2022 | Vesting/Settlement of Restricted Stock Units Compensation | 2.30K | — |
6/11/2021 | Vesting/Settlement of Restricted Stock Units Compensation | 4.01K | — |
| Total | 7K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7K
Market value
$32.2K
6/13/2025
Total
Units
7K
Value
$32.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/13/2025 | 7K | $32.2K | NASDAQ | Planned |
| Total | 7K | $32.2K | ||